Single-dose dexamethasone for mild-to-moderate asthma exacerbations: effective, easy, and acceptable

Area of Science:

• Pediatric Pulmonology
• Pharmacology
• Emergency Medicine

Background:

• Asthma exacerbations in children are commonly treated with oral steroids.
• Traditional treatment involves a 5-day course of prednisone or prednisolone.
• Concerns exist regarding compliance and side effects with longer steroid courses.

Purpose of the Study:

• To evaluate the efficacy of single-dose dexamethasone versus traditional multi-day oral steroids for pediatric asthma exacerbations.
• To determine if a shorter steroid regimen can achieve similar clinical outcomes.
• To assess the feasibility and benefits of single-dose dexamethasone in various clinical settings.

Main Methods:

• Review of recent evidence comparing single-dose dexamethasone with 5-day courses of prednisone/prednisolone.
• Analysis of treatment outcomes, including symptom resolution and relapse rates.
• Consideration of drug properties like half-life and anti-inflammatory potency.

Main Results:

• Single-dose dexamethasone demonstrates comparable outcomes to traditional 5-day oral steroid courses for mild-to-moderate pediatric asthma exacerbations.
• Dexamethasone's longer half-life and potent anti-inflammatory effects contribute to its efficacy.
• Easier administration and improved compliance are noted benefits.

Conclusions:

• Single-dose dexamethasone is a viable and effective alternative for treating pediatric asthma exacerbations.
• This approach simplifies treatment and enhances patient compliance.
• It is suitable for use in office, urgent care, and emergency department settings.